When and How Investigators Should Obtain Informed Consent and HIPAA Authorization

Informed Consent Requirements

Before you conduct any study-specific activity—including screening that collects data for research—you must obtain informed consent. Consent is an ongoing dialogue that begins at first contact and continues through participation, amendments, and closeout. It safeguards research participant rights and lays out how you will respect autonomy, privacy, and safety.

What makes consent legally effective

• Voluntary, free from coercion or undue influence, with clear options to decline or withdraw at any time.
• Obtained from individuals with decision-making capacity or from a legally authorized representative (LAR) when capacity is lacking.
• Presented in understandable language, using plain terms and an interpreter when needed.
• Allows ample time for questions and consideration, with access to study staff for clarification.
• Contains no exculpatory language waiving legal rights or releasing liability for negligence.

Informed consent form elements

• Study purpose, expected duration, and what participation involves, including procedures and visit schedules.
• Foreseeable risks, discomforts, and measures to minimize them, plus any unknowns.
• Expected benefits to the participant or others, and a frank statement when direct benefit is unlikely.
• Alternatives to participation, including standard care or no participation.
• Confidentiality protections, data handling, and whether Protected Health Information (PHI) will be used.
• Compensation, payments, costs, and injury care information, if applicable.
• Voluntariness, withdrawal process, and any consequences of withdrawal for clinical care.
• Contacts for questions about the study, participant rights, and research-related injuries.
• New findings that may affect willingness to continue, and how these will be communicated.
• Estimated number of participants, specimen/data banking plans, and future use or sharing, if proposed.

Timing and conduct of the consent conversation

• Discuss consent in a private setting, using teach-back to confirm understanding.
• Provide the approved consent form in advance when feasible, with enough time to review and consult others.
• Use calibrated reading levels and translated materials; involve an interpreter for non-English speakers.
• For remote or e-consent, use secure platforms that capture identity, time stamps, and audit trails.

HIPAA Authorization Requirement

If your research uses, creates, or discloses PHI from a covered entity, you must obtain HIPAA Authorization unless an Institutional Review Board (IRB) or Privacy Board approves a waiver or alteration. You may integrate HIPAA Authorization with the consent form to streamline the process while keeping required elements intact.

HIPAA Authorization elements

• A specific description of the PHI to be used or disclosed (for example, labs, diagnoses, visit dates).
• Who may use or disclose the PHI and who may receive it (research team, sponsor, data coordinating center).
• The purpose of the use/disclosure (the specific study and, if applicable, future research uses as described).
• An expiration date or event (for example, “end of research plus X years” or “none” if permitted with explanation).
• Participant or LAR signature and date, with a copy provided to the signer.
• Statements about the right to revoke in writing, how to do so, and limits on revocation once data are used.
• A notice that redisclosure by recipients may not be protected by HIPAA.
• Whether signing is required for research-related treatment, and that clinical care is not conditioned on signing when not applicable.

Integrating Authorization with consent

• Use a combined document with clear headings separating consent and HIPAA Authorization elements.
• For compound authorizations, distinguish required and optional future-use components so participants can opt in or out.
• Explain any data sharing, de-identification, and data retention periods in accessible terms.

Documentation of Consent

Documenting consent confirms that you followed a compliant process and that the participant agreed knowingly. Your documentation must match the IRB-approved materials and reflect exactly what the participant was told and signed.

Acceptable documentation methods

• Written consent: participant (or LAR) signs and dates the IRB-approved form; provide a signed copy.
• Short-form consent: use a translated short form with an interpreter and an IRB-approved summary; obtain signatures from the participant, a witness, and the person obtaining consent.
• Waiver of documentation: when approved by the IRB, record a dated note describing the conversation, comprehension checks, and the waiver determination.
• Electronic consent: capture electronic signatures, version control, identity verification, and an audit trail; furnish an electronic or paper copy to the participant.

What to record in the research file

• Consent date/time, version number, and who obtained consent; note presence of LAR, witness, or interpreter.
• Language used and materials provided (including translations and supplemental summaries).
• Key questions asked, teach-back results, and any study-specific clarifications.
• Copies provided to the participant and method of delivery (paper, portal, secure email).

Waiver of Informed Consent and HIPAA Authorization

An IRB may approve an Institutional Review Board (IRB) waiver or alteration when strict criteria are met. You must justify why the waiver is necessary and how participant privacy and welfare will be protected.

Waiver or alteration of informed consent

• The research presents no more than minimal risk to participants.
• The waiver will not adversely affect participants’ rights and welfare.
• The research is impracticable without the waiver or alteration.
• When appropriate, pertinent information will be provided after participation (for example, in some deception studies).

Waiver of documentation of consent

• The only record linking the participant and the research would be the consent document, and the principal risk is a breach of confidentiality; or
• The research presents no more than minimal risk and involves no procedures for which written consent is normally required outside of research.

HIPAA waiver or alteration

• Minimal risk to privacy with an adequate plan to protect identifiers and destroy them when no longer needed.
• Research impracticable without the waiver and without access to the PHI.
• Written assurances that PHI will not be reused or disclosed except as required by law or for oversight.

Common use cases

• Retrospective chart reviews using existing records where contacting all individuals is impracticable.
• Feasibility pre-screening via partial HIPAA waivers to identify eligible patients before consent.
• Public health–relevant minimal-risk surveys that do not require written signatures.

Consent Process for Vulnerable Populations

Vulnerable population consent demands enhanced safeguards to ensure equitable selection, comprehension, and voluntariness. Tailor the process to the population while preserving respect and autonomy.

Children and adolescents

• Obtain parental permission and the child’s assent when capable, using age-appropriate materials.
• Re-consent individuals who reach the legal age of consent during longitudinal studies.

Adults with impaired decision-making capacity

• Assess capacity; when lacking, seek consent from an LAR under applicable laws.
• Seek assent whenever possible and respect dissent.

Prisoners

• Ensure additional IRB protections and impartial consent processes free of coercion.
• Address constraints on privacy and voluntariness in the setting.

Pregnant participants and fetuses

• Describe maternal and fetal risks clearly, including unknowns and monitoring plans.
• Coordinate with clinical care to avoid therapeutic misconception.

Non-English speakers and low literacy

• Use fully translated, IRB-approved documents or a short-form process with an interpreter.
• Deploy visuals and teach-back to confirm understanding; avoid technical jargon.

Students, employees, and economically disadvantaged individuals

• Minimize undue influence by separating evaluators from recruiters and offering non-coercive compensation.
• Emphasize voluntariness and confidentiality of employment or academic status.

Role of IRB in Consent and Authorization

The IRB ensures that participants receive legally effective consent and that privacy protections are adequate. It reviews, approves, and oversees materials and processes throughout the study lifecycle.

Core IRB responsibilities

• Approve consent forms, recruitment materials, and HIPAA Authorization language before use.
• Verify that informed consent form elements and HIPAA Authorization elements are complete and comprehensible.
• Evaluate and document determinations for any waiver or alteration of consent or HIPAA Authorization.
• Require additional safeguards for vulnerable populations and high-risk interventions.
• Review amendments, new risk information, and reportable events; require re-consent when warranted.
• Serve as a Privacy Board when issuing HIPAA waivers or alterations.

Consent Process Documentation

Robust records demonstrate compliance, support monitoring, and protect participants. Build documentation into your workflow and maintain version control across the study.

Operational checklist for investigators

• Confirm the current IRB-approved consent and Authorization versions before each use.
• Prepare a private setting, translated materials, and an interpreter or assistive tools as needed.
• Use a script and teach-back; note participant questions and clarifications.
• Capture all required signatures, dates, and roles (participant, LAR, witness, interpreter).
• Provide copies and record delivery method; secure storage of originals.

Storage, access, and confidentiality

• Store signed documents and PHI in secure, access-controlled locations with audit trails.
• Limit access to authorized study personnel; document training and role-based permissions.
• Follow retention schedules and destruction plans consistent with IRB and institutional policy.

Re-consent and updates

• Re-consent when new information could affect willingness to continue, when procedures change, or when risk increases.
• Track participants who require updated consent; document the date, version, and method used.
• Record HIPAA revocations and honor them prospectively while retaining data already used per policy.

Remote and electronic processes

• Implement identity verification, time stamps, and immutable audit logs for e-consent.
• Ensure availability of the consent document for download or printing.
• Validate systems for reliability and train staff; document any technical issues and resolutions.

Conclusion

Obtaining and documenting informed consent and HIPAA Authorization is a deliberate, participant-centered process. By using complete elements, ensuring comprehension, protecting PHI, and engaging the IRB appropriately—including when seeking an Institutional Review Board (IRB) waiver—you uphold legally effective consent and the core values of ethical research.

FAQs

When must informed consent be obtained from research participants?

Obtain consent before any study-specific procedures, including eligibility screening that collects data for research. Consent is ongoing, so you should revisit it when risks change, procedures are amended, or participants reach the age of majority in longitudinal studies.

How can HIPAA Authorization be integrated with informed consent?

Use a combined document that clearly distinguishes the informed consent content from HIPAA Authorization elements. Specify the PHI involved, who will use or receive it, the purpose, expiration, revocation rights, and any optional future-use authorizations so participants can make separate choices.

What circumstances allow for a waiver of informed consent or HIPAA Authorization?

An IRB may grant a waiver or alteration when the research poses no more than minimal risk, rights and welfare are protected, and the research is impracticable without the waiver. HIPAA waivers additionally require a plan to protect and destroy identifiers and assurances against improper reuse or disclosure.

How should investigators document the consent and authorization process?

Use the IRB-approved versions, capture required signatures and dates, and record the conversation details—language used, interpreter involvement, questions asked, and teach-back results. Provide copies to participants, secure PHI, maintain audit-ready files, and track re-consent or HIPAA revocations over time.